# Blopress Tablets Specified Drug-use Survey "Hypertension: Survey on Patients With Metabolic Syndrome"

> **NCT02166697** · — · COMPLETED · sponsor: **Takeda** · enrollment: 14151 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** candesartan cilexetil

## Key facts

- **NCT ID:** NCT02166697
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 14151 (ACTUAL)
- **Last updated:** 2016-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02166697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02166697, "Blopress Tablets Specified Drug-use Survey "Hypertension: Survey on Patients With Metabolic Syndrome"". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02166697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*